1.866.448.4864
How KINOMEscan™ Competition Binding Assays Work - DiscoveRx

TECHNOLOGY – 

KINOMEscan™

Assay Principle

Compounds that bind the kinase active site, which directly (sterically) or indirectly (allosterically) prevent kinase binding to the immobilized ligand, will reduce the amount of kinase captured on the solid support (Panels A & B). Conversely, test molecules that do not bind the kinase have no effect on the amount of kinase captured on the solid support (Panel C). Screening "hits" are identified by measuring the amount of kinase captured in test versus control samples by using a quantitative, precise and ultra-sensitive qPCR method that detects the associated DNA label (Panel D). In a similar manner, dissociation constants (Kds) for test compound-kinase interactions are calculated by measuring the amount of kinase captured on the solid support as a function of the test compound concentration.

Click here to learn more»

 

Copyright ©2009, DiscoveRx Corporation. TERMS AND CONDITIONS

Contact Us  |   Privacy Policy  |   Site Map  |   Careers